BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Farooq R, Hussain K, Tariq M, Farooq A, Mustafa M. CRISPR/Cas9: targeted genome editing for the treatment of hereditary hearing loss. J Appl Genet 2020;61:51-65. [PMID: 31912450 DOI: 10.1007/s13353-019-00535-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Vyas P, Wood MB, Zhang Y, Goldring AC, Chakir FZ, Fuchs PA, Hiel H. Characterization of HA-tagged α9 and α10 nAChRs in the mouse cochlea. Sci Rep 2020;10:21814. [PMID: 33311584 DOI: 10.1038/s41598-020-78380-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Eshraghi AA, Polineni SP, Davies C, Shahal D, Mittal J, Al-Zaghal Z, Sinha R, Jindal U, Mittal R. Genotype-Phenotype Correlation for Predicting Cochlear Implant Outcome: Current Challenges and Opportunities. Front Genet 2020;11:678. [PMID: 32765579 DOI: 10.3389/fgene.2020.00678] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]